HDAC2 and primary cutaneous T-cell non-Hodgkin lymphoma: In a study that investigated the differential expression and prognostic significance of HDACs in CTCL, HDAC2 was found to be more highly expressed in the aggressive types of CTCL than in the indolent ones.